All reports
Pharmaceutical
Oncology, Cell & Gene Therapy
Cell and Gene Therapy Manufacturing: CDMO and Capacity
Code: NSC/PHRM/0010Published Mar 30, 2026Data window: 12 months
About this report
Lonza, Catalent, Samsung Biologics, WuXi: viral vector, lentivirus capacity, automation.
Humans at the core of the analysis
Partner specialist firms, independent domain experts and our in-house analyst team: every report is written and reviewed by humans who cross-check signals, verify sources and prioritise what matters.
Key insights
Request the sample to discover the report's key insights.
Table of contents
The detailed table of contents is shared with the free sample.